- Precautions re: Pregnant or Nursing or Prescription Medications
- If pregnant, nursing, or taking prescription drugs, consult your healthcare practitioner prior to use.
- General Statements: All Other Content
- For Sale in North America only. U.S. Patent 5,925,620
- General: Product/Version Code
- LI236006.B04 (B010133B)
- FDA Disclaimer Statement
- THIS STATEMENT HAS NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE.
- General Statements: All Other Content
- PREMIER SCIENCE
- General Statements: All Other Content
- Convenient Delivery for Advanced Support
Manages healthy cell apoptosis, promotes cellular detoxification, and blocks free-radical damage
- FDA Statement of Identity
- Dietary Supplement
- Formulation re: Does NOT Contain
- Contains no sugar, salt, yeast, wheat, gluten, corn, soy, dairy products, artificial coloring, artificial flavoring, or preservatives.
- General Statements: All Other Content
- This product contains natural ingredients; color variations are normal.
- Brand IP Statement(s) re: (c), (TM), (SM)
- AnthoRedoxin(TM) is a blend of anthocyanins exclusive to ITI(R).
- Brand IP Statement(s) re: (c), (TM), (SM)
- Recancostat(R) is a patented combination of stabilized reduced glutathione (GSH), anthocyanins, and L-cysteine, clinically studied to support cell apoptosis and healthy cell development.
- General Statements: All Other Content